Description: Medicare Advantage plans have been in the market for two decades. In this session, we survey the landscape changes from 2006 up to now, which include but not limited to the changes of enrollment, plan types, big players' market share, policies, and how players as well as beneficiaries react to the changes. This session intends to provide general MA knowledge and history to the audience with or without Medicare Advantage background.

Description: Is 2024 the year you need to implement U.S. GAAP Long-Duration Targeted Improvements for individual health insurance products? In this session, we will discuss implementation and the importance of working with accountants and IT to ensure a successful implementation. Some requirements will be a surprise to health actuaries.

Description: Sarah Rockhill, MPH, Geospatial Epidemiologist at CDC will discuss the latest in the Public Health 3.0 model in which leaders serve as Chief Health Strategists, partnering across multiple sectors and leveraging data and resources to address social, environmental, and economic conditions that affect health and health equity.

Description: Value-based care (VBC) arrangements have grown exponentially in recent years with an expectation that this shift will only continue across the health care industry. CMS has set the goal of having 100% of traditional Medicare and the vast majority of Medicaid beneficiaries in accountable care relationships by 2030.

Description: A summary recap of the recent SOA Health Conference held in Dallas, TX in June of 2025. With the intentional use of AI to assist with the summary, this article gives a good overview of the recent conference with personal commentary from one of the attendees.

Description: The presenters will discuss market impacts of Affordable Care Act (ACA) risk adjustment results with a focus on recently released 2024 results. Their discussion will include the challenges of a single risk adjustment model and the growing state variations that impact risk dynamics.

Description: Virtual - Session 1D: Pharmacy Risk Mitigation - Pricing, Programs, Pools, and Performance Guarantees

Description: Session 4C: The Impact of Medical Advancements on Disability and Group Life

Description: Session 10B: Comprehensive PBM Performance Evaluations Including TCOC Impact

Description: This is an article that highlights recommended reading by the Health Practice area communications committee. The readings cover a broad subject matter from risk assessment, medical technology to uninsured.